An Overview of Rowasa and Breastfeeding
Because of the potential serious side effects that could occur in the nursing infant, the manufacturer of
Rowasa® (
mesalamine) recommends that the drug be used cautiously in women who are breastfeeding. Therefore, if you are breastfeeding or thinking of breastfeeding and have been prescribed Rowasa, make sure to let your healthcare provider know.
What Does the Research Say About Rowasa and Breastfeeding?
Mesalamine (the active ingredient of Rowasa) passes through breast milk when taken orally. However, since mesalamine is not absorbed well into the bloodstream when taken rectally, it is not known if Rowasa can pass through breast milk. If your healthcare provider recommends using Rowasa while breastfeeding, be sure to watch for any side effects in your child.
Talking With Your Healthcare Provider About Rowasa and Breastfeeding
You should talk with your healthcare provider about Rowasa and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. After considering what you want and expect (and your current health situation), you and your healthcare provider can make a shared decision about Rowasa and breastfeeding for your particular situation.